WebICD-10-CM Code C56.9Malignant neoplasm of unspecified ovary. BILLABLE Female Only ICD-10 from 2011 - 2016. C56.9 is a billable ICD code used to specify a diagnosis of malignant neoplasm of unspecified ovary. A 'billable code' is detailed enough to be used to specify a medical diagnosis. WebHospitalizations with main diagnosis of malignant cancer of ovary (ICD-10: C56) and ovarian surgery by type of operation, surgical approach and calendar time in Germany 2005–2015 (N = 77,406).
Billing and Coding: Positron Emission Tomography Scans Coverage
WebC00-C75 - Malignant neoplasms, stated or presumed to be primary (of specified sites), and certain specified histologies, except neuroendocrine, and of lymphoid, hematopoietic and related tissue. C51-C58 - Malignant neoplasms of female genital organs. C56 - Malignant neoplasm of ovary. C56.1 - Malignant neoplasm of right ovary. WebApr 7, 2024 · ICD-10-CM Diagnosis Codes. C56.2 - Malignant neoplasm of left ovary. The above description is abbreviated. This code description may also have Includes, Excludes, Notes, Guidelines, Examples and other information. Access to this feature is available in the following products: Find-A-Code Essentials. HCC Plus. Find-A-Code Professional. txwes career services
C56.9 - Malignant neoplasm of unspecified ovary ICD-10-CM
WebC56. ICD-10-CM Code for Malignant neoplasm of uterus, part unspecified C55 ICD-10 code C55 for Malignant neoplasm of uterus, part unspecified is a medical classification as listed by WHO under the range - Malignant neoplasms . Subscribe to Codify by AAPC and get the code details in a flash. Weba. In the Endometrioid Carcinoma example, a specific code, C56.9, Carcinoma, endometrioid, female, is listed in the ICD-10-CM Index to Diseases and Injury. Example for Step 2: Endometrioid Carcinoma in a Female, Step 2 Carcinoma -endometrioid --unspecified site ---female C56.9 Because the code has been identified, proceed to Step 4. b. Web10. Code History. C56.9 is a billable ICD-10 code used to specify a medical diagnosis of malignant neoplasm of unspecified ovary. The code is valid during the fiscal year 2024 from October 01, 2024 through September 30, 2024 for the submission of HIPAA-covered transactions. This code is applicable to female patients only. txwes.edu